Brief: U.S. FDA Grants Fast Track Designation For Longeveron’s Lomecel-B

Longeveron

31/08/2022 13:33

Aug 31 (Reuters) - Longeveron Inc  LGVN.O :
    * U.S. FOOD AND DRUG ADMINISTRATION (FDA) GRANTS FAST TRACK
DESIGNATION FOR LONGEVERON’S LOMECEL-B™ PRODUCT FOR TREATMENT OF
HYPOPLASTIC LEFT HEART SYNDROME (HLHS) IN INFANTS

Source text for Eikon:  ID:nGNX3Svfjl 
Further company coverage:  LGVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))